These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30332404)

  • 41. HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting.
    Duncombe C; Kerr SJ; Ruxrungtham K; Dore GJ; Law MG; Emery S; Lange JM; Phanuphak P; Cooper DA
    AIDS; 2005 Jan; 19(2):169-78. PubMed ID: 15668542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis.
    Inzaule SC; Kroeze S; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Steegen K; Nankya I; Boender TS; Ondoa P; Sigaloff KCE; de Wit TFR; Hamers RL
    AIDS; 2022 Aug; 36(10):1437-1447. PubMed ID: 35608116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
    AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.
    Kawai K; Hawkins CA; Hertzmark E; Francis JM; Sando D; Muya AN; Ulenga N; Fawzi WW
    Am J Trop Med Hyg; 2018 Feb; 98(2):396-401. PubMed ID: 29313475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
    Tweve EN; Kayabu D; Nassari NO; Todd J
    Trop Med Int Health; 2015 Jun; 20(6):791-6. PubMed ID: 25706518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data.
    Kufa T; Shubber Z; MacLeod W; Takuva S; Carmona S; Bor J; Gorgens M; Pillay Y; Puren A; Eaton JW; Fraser-Hurt N
    PLoS One; 2019; 14(5):e0217742. PubMed ID: 31150489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
    J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.
    Franke MF; Kaigamba F; Socci AR; Hakizamungu M; Patel A; Bagiruwigize E; Niyigena P; Walker KD; Epino H; Binagwaho A; Mukherjee J; Farmer PE; Rich ML
    Clin Infect Dis; 2013 May; 56(9):1319-26. PubMed ID: 23249611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART.
    Ceccherini-Silberstein F; Cozzi Lepri A; Alteri C; Merlini E; Surdo M; Marchetti G; Capobianchi MR; De Luca A; Gianotti N; Viale P; Andreoni M; Antinori A; Perno CF; d'Arminio Monforte A;
    J Antimicrob Chemother; 2018 Dec; 73(12):3460-3470. PubMed ID: 30247724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course.
    Raffi F; Le Moing V; Assuied A; Habak S; Spire B; Cazanave C; Billaud E; Dellamonica P; Ferry T; Fagard C; Leport C;
    J Antimicrob Chemother; 2017 Jan; 72(1):240-245. PubMed ID: 27629069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antiretroviral treatment discontinuation and its influencing factors among HIV-infected patients who initiated ART from 2012 to 2015 in Wenshan prefecture, Yunnan Province].
    Hu XS; Zhao Y; Huang LL; Luo YX; Wu ZY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Nov; 51(11):982-987. PubMed ID: 29136742
    [No Abstract]   [Full Text] [Related]  

  • 55. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?
    Saunders P; Goodman AL; Smith CJ; Marshall N; O'Connor JL; Lampe FC; Johnson MA
    HIV Med; 2016 Jan; 17(1):18-27. PubMed ID: 26140659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
    Silveira MP; Silveira CP; Guttier MC; Page K; Moreira LB
    J Clin Pharm Ther; 2016 Dec; 41(6):689-694. PubMed ID: 27676134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.
    Stockdale AJ; Nkuranga J; Török ME; Faragher B; Lalloo DG
    Trop Med Int Health; 2013 Jul; 18(7):907-14. PubMed ID: 23590229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
    J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.